• The Journal of Internal Korean Medicine
• /
• v.39 no.2
• /
• pp.139-146
• /
• 2018

Objective: The purpose of this clinical study is to report the effect of Banhahoobak-tang in the case of a 57-year-old woman with multiple cerebral infarction causing dysphagia and dysarthria diagnosed as pseudobulbar palsy. Methods: A patient was treated with Korean medicine, including herbal medication, acupuncture, and language therapy. We focused on the effect of Banhahoobak-tang by evaluating improvements in symptoms by examining times of aspiration and changes in Speech Mechanism Screening Test scores. Results: After three months of Korean medicine treatment and language therapy, there was improvement in the patient's symptoms, including dysphagia and dysarthria. Conclusions: This study suggests that Korean medicine treatment could be effective for improving the symptoms of pseudobulbar palsy in patients. Specifically, herbal medicine (Banhahoobak-tang) could be an effective choice for treating dysphagia.

• Journal of Korean Neurosurgical Society
• /
• v.37 no.2
• /
• pp.124-128
• /
• 2005

Objective: Congenital bilateral perisylvian syndrome(CBPS) has been defined as a characteristic malformative perisylvian polymicrogyria(PMG) in patients with clinical symptoms of pseudobulbar palsy and epileptic seizures. For the present study, we investigate clinicopathologic features of CBPS associated with timing of lesion formation. Methods: Clinicopathologic features of CBPS from 6 patients with surgical resection of the cerebral lesions due to medically intractable seizures were studied. Results: Seizure onset ranged from 1 to 10years (average 6.7years) of age, and average duration of seizure was 23years. All had complex partial seizures, and two patients had additional tonic clonic seizures. Magnetic resonance (MR) images showed polymicrogyria, atropic gyri with gliosis. In the histopathologic examination, the cortical lesions revealed features of ulegyria; atrophic and sclerotic gyri, laminar loss of neurons, extensive lobular gliosis throughout the gray and white matter, neuronoglial nodule formation, and many amyloid bodies. Unlayered or four-layered PMG was not identified. Conclusion: Above data suggest that CBPS might be caused by ulegyria resulting from developmental cortical defect during early fetal stage or acquired hypoxic/ischemic injury in prenatal or postnatal life.

• The Korean Journal of Nuclear Medicine
• /
• v.30 no.1
• /
• pp.47-55
• /
• 1996

Progressive supranuclear palsy (PSP) is a parkinson-plus syndrome characterized clinically by supranuclear ephthalmoplegia, pseudobulbar palsy, axial rigidity, bradykinesia, postural instability and dementia. Presence of dementia and lack of cortical histopathology suggest the derangement of cortical function by pathological changes in subcortical structures in PSP, which is supported by the pattern of behavioral changes and measurement of brain metabolism using positron emission tomography. This study was done to examine whether there are specific changes of regional cerebral perfusion in PSP and whether there is a correlation between severity of motor abnormality and degree of changes in cerebral perfusion. We measured regional cerebral perfusion indices in 5 cortical and 2 subcortical areas in 6 patients with a clinical diagnosis of PSP and 6 healthy age and sex matched controls using $^{99m}Tc$-HMPAO SPECT. Compared with age and sex matched controls, only superior frontal regional perfusion index was significantly decreased in PSP (p<0.05). There was no correlation between the severity of the motor abnormality and any of the regional cerebral perfusion indices (p>0.05). We affirm the previous reports that perfusion in superior frontal cortex is decreased in PSP. Based on our results that there was no correlation between severity of motor abnormality and cerebral perfusion in the superior frontal cortex, nonmotoric symptoms including dementia needs to be looked at whether there is a correlation with the perfusion abnormality in superior frontal cortex.